Drug Database
Back to search

France· FR:69026054

OZIDIA 5 mg, comprimé à libération prolongée

A glipizide product containing glipizide, registered in France by PFIZER HOLDING FRANCE, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A10BB07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOZIDIA 5 mg, comprimé à libération pr…ATCA10BB07REGISTER NO.FR:69026054PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glipizideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glipizide is registered in 8 of 19 countries.

Countries holding a registration under ATC A10BB07 (glipizide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search glipizide products by name

Glipizide · ATC A10BB07

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Italyprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glipizide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.056 in United States to $0.39 in France — a ×7.0 gap.

  • France: $0.39 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Glipizide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • FR France$0.39
  • IT Italy$0.32
  • US United States$0.056 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
GLIPIZIDE
Manufacturer
PFIZER HOLDING FRANCE
Country
France (FR)
ATC code
A10BB07
ATC class
Glipizide
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933953935
    1 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
    EUR 5.34

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

745 interactions on record for glipizide.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glipizide against other medicinesHow interaction checks work

Glipizide · interactions on record

745 records

  • 20 severe
  • 448 moderate
  • 51 minor
  • 226 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glipizide in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glipizide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Czechia · Minidiab
  • Spain · Minodiab
  • United Kingdom (Northern Ireland) · Minodiab
  • Italy · Minidiab
  • Poland · Glipizide Bp Galena
  • Romania · Glucotrol Xl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4bcd6b6a-65c5-4943-b981-74c0cd672b44
GET /v1/drugs/4bcd6b6a-65c5-4943-b981-74c0cd672b44?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69026054",
  "date_amm": "1995-10-09",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "GLIPIZIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé à libération prolongée",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about glipizide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console